Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.48 |
| ▸ | CA2 | P00918 | 4/20 | 0.48 |
| ▸ | CA7 | P43166 | 2/20 | 0.48 |
| ▸ | CA9 | Q16790 | 2/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA4 | P22748 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | IDO1 | P14902 | 1/20 | 0.42 |
| ▸ | TDO2 | P48775 | 1/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.41 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9717423 | 0.82 | KCNK3 (0.44) | CA1CA2CA9CA12ACHE | |
| SCHEMBL15331984 | 0.81 | CA1 (0.50) | CA1CA2CA7CA9CA12 | |
| SCHEMBL27540019 | 0.80 | IMPDH2 (0.46) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL27842200 | 0.80 | HTR2C (0.39) | KMT2AHTTALDH1A1TSHRMEN1 | |
| SCHEMBL1822664 | 0.80 | CA1 (0.38) | CA1CA2ACHEL3MBTL1ALDH1A1 | |
| SCHEMBL27624241 | 0.80 | KCNK3 (0.44) | L3MBTL1ALDH1A1KCNK3KCNK9 | |
| SCHEMBL4981765 | 0.79 | HTT (0.66) | CA1CA2CA7CA9CA12 | |
| SCHEMBL5759427 | 0.78 | CA1 (0.46) | CA1CA2CA7CA9CA12 | |
| SCHEMBL8698872 | 0.78 | CA1 (0.46) | CA1CA2CA7CA9CA12 | |
| SCHEMBL169082 | 0.78 | CA1 (0.46) | CA1CA2CA7CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1432416-A1 | AMINOINDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Pharmacia Italia S.p.A. (IT) | 2004-06-30 | — | — | EP | claimed |
| WO-2003028720-A1 | AMINOINDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | PHARMACIA ITALIA S.P.A. (IT) | 2003-04-10 | — | — | WO | claimed |
| US-20260096991-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | XAMPLA LTD (GB) | 2026-04-09 | — | — | US | disclosed |
| EP-4489592-B1 | BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION | XAMPLA LTD (GB) | 2025-12-24 | — | — | EP | disclosed |
| US-20250255827-A1 | BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION | XAMPLA LIMITED (GB) | 2025-08-14 | — | — | US | disclosed |
| EP-4593639-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | Xampla Limited (GB) | 2025-08-06 | — | — | EP | disclosed |
| US-20250186960-A1 | BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION | XAMPLA LIMITED (GB) | 2025-06-12 | — | — | US | disclosed |
| EP-3888782-B1 | COATED MICROCAPSULES | NOXELL CORP (US) | 2025-06-11 | — | — | EP | disclosed |
| US-20250177298-A1 | EMULSIONS AND A METHOD FOR THEIR PREPARATION | XAMPLA LIMITED (GB) | 2025-06-05 | — | — | US | disclosed |
| WO-2025109106-A1 | CORE-SHELL MICROCAPSULES | XAMPLA Ltd. (GB) | 2025-05-30 | — | — | WO | disclosed |
| CN-119698412-A | 5-HT2A receptor agonist, and preparation method and application thereof | 上海翊石医药科技有限公司 | 2025-03-25 | — | — | CN | disclosed |
| US-20140221269-A1 | OLFACTORY SIGNATURE AND ODORANT MIXTURE HAVING THE SAME | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2014-08-07 | — | — | US | disclosed |
| CN-101616659-B | Personal care compositions containing silicone elastomer gels | DOW CORNING | 2013-08-28 | — | — | CN | disclosed |
| WO-2013035070-A1 | OLFACTORY SIGNATURE AND ODORANT MIXTURE HAVING THE SAME | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2013-03-14 | — | — | WO | disclosed |
| CN-101616659-A | The personal care composition that contains silicone elastomer gels | DOW CORNING | 2009-12-30 | — | — | CN | disclosed |
| CN-101394826-A | Silicone vesicles containing actives | DOW CORNING (US) | 2009-03-25 | — | — | CN | disclosed |
| CN-1878528-A | Mixture with wintergreen odor and flavor | SYMRISE GMBH & CO KG (DE) | 2006-12-13 | — | — | CN | disclosed |
| US-5973156-A | Piperidine and tetrahydropyridine derivatives | MERCK SHARP & DOME LTD. (GB) | 1999-10-26 | — | — | US | disclosed |
| EP-0861245-A1 | PIPERIDINE AND TETRAHYDROPYRIDINE DERIVATIVES | MERCK SHARP & DOHME LTD. (GB) | 1998-09-02 | — | — | EP | disclosed |
| WO-1997019073-A1 | PIPERIDINE AND TETRAHYDROPYRIDINE DERIVATIVES | MERCK SHARP & DOHME LIMITED (GB) | 1997-05-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260096991-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | PCTP, CLK4, MTCL3 | CA1 2576/4885CA2 2101/4885CA7 3266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.